跳至主要内容
临床试验/EUCTR2007-006049-41-AT
EUCTR2007-006049-41-AT进行中(未招募)不适用

Evaluation of Tacrolimus (Prograf®) intraportal infusion during the implantation and the protective effect on ischemia-reperfusion injury in orthotopic liver transplant recipients - single center study

Medizinische Universität Wien; Univ.Klin.f. Chirurgie; Klin. Abtlg. f. Transplantation0 个研究点目标入组 26 人开始时间: 2008年1月29日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
26

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Inclusion criteria
  • - Patients, who are listed on the liver transplant-waiting list at the Vienna General Hospital and who fulfil the clinical requirements (local allocation)
  • - Written informed consent
  • - Age > 18
  • - First transplantation
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Exclusion criteria
  • - Fulminant failure of the liver
  • - Liver-Living donor recipients
  • - Multiorgantransplantation or retransplantation
  • - ABO incompatible donor organ recipients
  • - pregnant or nursing women
  • - Allergy/Intolerance to antimetaboliten, HCO-60, EL Cremophor or similar compounds
  • Steroids or Macrolid antibiotics
  • - HIV-positive donors or recipients
  • - Participants of another clinical study

研究者

发起方
Medizinische Universität Wien; Univ.Klin.f. Chirurgie; Klin. Abtlg. f. Transplantation

相似试验